10mg semaglutide UPB Sema (Single Agonist) Semaglutide (10mg) + Tirzepatide (10mg)

However, Goldman says it would benefit people if we discussed the drugs differently

This premium is directly tied to its status as a triple agonist. While semaglutide only mimics one hormone and tirzepatide mimics two, retatrutides addition of the glucagon pathway increases energy expenditure in research models, making it a highly valuedand therefore costlyasset

A companion phase III trial reported a -10.9% reduction in visceral adipose tissue (a 21 cm decrease) in the tesamorelin group compared with -0.6% in the placebo group over the six-month efficacy phase, alongside significant improvements in trunk fat, waist circumference, and waist-hip ratio, with the authors concluding that tesamorelin reduces visceral fat by approximately 18% and improves body-image distress in HIV-infected patients with central fat accumulation, without significant side effects or disruption of glucose control

However, the catch is finding the right dosage

Code BRAINFLOW saves 10%

Clinical considerations and risk profile Although GLP-1 therapies are highly effective, they are not without risks